JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
- Issues related to Trans-Pacific Partnership agreement. - Issues related to Transatlantic Trade and Investment Partnership. - Issues related to the appointment of a dedicated healthcare trade official
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID KAVANAUGH | — |
Taxation/Internal Revenue Code TAX
- HR 1270/S 709, "Restoring Access to Medication Act of 2015", regarding all provisions. - Issues related to tax reform. - Issues related to CFC Look through permanency. - Issues related to R&D credit. - Issues related to Mobile Workforce legislation. - Issues related to Cadillac Tax. - Issues related to OECD tax reporting. - Issues related to Repatriation holiday. - Issues related to Puerto Rico tax treatment. - Issues related to flexible spending accounts tax treatment. - HR 4900/ HR 5278/ S 2328, "PROMESA", regarding provisions related to Puerto Rico debt restructuring. - H.Res 770, "Providing for consideration of the bill (H.R. 5278) to establish an Oversight Board to assist the Government of Puerto Rico, including instrumentalities, in managing its public finances, and for other purposes.", regarding all provisions. - Issues related to treasury debt/equity rules.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE BRUCE | — |
| BRIAN BURNS | — |
| PEDRO TOMAS COSTA New | — |
| DARREL C JODREY | — |
| DAVID KAVANAUGH | — |
Copyright/Patent/Trademark CPT
- HR 9, "Goodlatte Innovation Act", regarding all provisions - S 632, "STRONG Patents Act of 2015", regarding all provisions - Issues related to the re-introduction of the Patent Abuse Act - Issues related to BARDA and other Ebola related matters. - Issues related to biosimilar reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| CHARLES NAU | — |
Health Issues HCR
- H 2, "Medicare Access and CHIP Reauthorization Act of 2015", regarding all provisions. - HR 1078, "Food and Drug Administration Safety Over Sequestration Act of 2015", regarding all provisions. - S 1622, "FDA Device Accountability Act of 2015", regarding all provisions. - HR 6, "21st Century Cures Act", regarding all provisions. - S 993, "Comprehensive Justice and Mental Health Act of 2015", regarding all provisions. - Issues related to physician-owned companies that manufacture or distribute medical devices. - Issues relating to cosmetic regulatory reform. - Issues related to 340B payments to hospitals. - Issues related to pseudoephedrine. - Issues related to dextromethorphan. - Issues related to legislation that would modify the Medicare Part B drug reimbursement program. - Issues related to legislation that would establish a rebate in the Medicare Part D program. - Issues related to Pub.L. 108-164, "Fairness to Contact Lens Consumers Act" (FCLCA) and related FTC Contact Lens Rule. - S.2977, "The Medical Electronic Data Technology Enhancement for Consumers' Health" (MEDTECH Act), regarding all provisions. - H.R. 3250, "DXM Abuse Prevention Act of 2015", regarding all provisions. - S. 2994, "DXM Abuse Prevention Act of 2016", regarding all provisions. - S. 1767, "The Combination Products Regulatory Fairness Act of 2015", regarding all provisions. - HR 2646, "Helping Families in Mental Health Crisis Act of 2015", regarding all provisions. - HR 1854, "Comprehensive Justice and Mental Health Act of 2015", regarding all provisions. - S. 1014, "Personal Care Products Safety Act", regarding all provisions. - S. 2777, "Contact lens Consumer Health Protection Act of 2016", regarding all provisions. - Issues related to Medicare Part B Demo - Issues related to Expanded Access in Senate Innovation Package - Issues related to Self monitoring of blood glucose meters. - HR 4075, "Cosmetic Modernization Amendments of 2015", regarding all provisions. - HR 1192, "National Clinical Care Commission Act", regarding all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| ANNE BRUCE | — |
| BRIAN BURNS | — |
| CARLA CARTWRIGHT New | — |
| LAURYL DODSON JACKSON | — |
| DARREL C JODREY | — |
| DAVID KAVANAUGH | — |
| BRIAN T KELLY | — |
| CHARLES NAU | — |
| MARK REESE | — |
Medicare/Medicaid MMM
- HR 1427/S 804, "Medicare CGM Access Act of 2015", regarding all provisions. - HR 284, "Medicare DMEPOS Competitive Bidding Improvement Act of 2015", regarding all provisions. - Issues regarding combination products. - Issues regarding Transferable Regulatory Exclusivity Incentive. - Issues related to Expanded Access. - S. 2736/ HR 5210, "Patient Access to Durable Medical Equipment Act of 2016", regarding all provisions. - Issues related to competitive bidding for DME products. - S. 2484, "Connect for Health Act", Provisions related to expanded use of RPM for certain patients with chronic conditions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| ANNE BRUCE | — |
| LAURYL DODSON JACKSON | — |
| BRIAN T KELLY | — |
| MARK REESE | — |
Budget/Appropriations BUD
- HR 83, "Consolidate and Further Continuing Appropriations Act, 2015", provisions related to emergency supplemental funding to address the Ebola epidemic domestically and internationally. - Issues related to the funding of the Biomedical Advanced Research and Development Authority. - Issues related to FDA Funding. - Issues related to VA procurement. - S. 3067/ HR 5485 - Financial Services and General Appropriations Act of 2017 - Issues related to FTC funding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| ANNE BRUCE | — |
| BRIAN BURNS | — |
| DARREL C JODREY | — |
| BRIAN T KELLY | — |
| CHARLES NAU | — |
Environment/Superfund ENV
- S 697, "Frank R. Lautenberg Chemical Safety for the 21st Century Act", regarding all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREL C JODREY | — |
Animals ANI
- Issues relating to animal testing. - HR 2858, "Humane Cosmetics Act", regarding all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREL C JODREY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.